ReNeuron's hRPC stem cells improve vision in first cohort of retinitis pigmentosa patients

ReNeuron Group plc (LSE:RENE) said a single subretinal implantation of its hRPC stem cells led significant improvements in visual acuity in three patients with retinitis pigmentosa

Read the full 262 word article

User Sign In